Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × Positron Emission Tomography Computed Tomography × Clear all

Sponsor

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hodgkin Disease 1 Hepatic Malignancies 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Cancer Diagnosis 1 Breast Cancer Metastases 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 11 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 Leucovorin 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡